Current law establishes a $100 cap on a person's 30-day supply of prescription insulin. The act clarifies that this cap is for the person's entire insulin supply, regardless of the number of prescriptions the person may have.
Beginning January 1, 2022, the act also:
- Requires pharmacists to provide eligible individuals with access to one emergency prescription insulin supply within a 12-month period at a cost not to exceed $35 for a 30-day supply; and
- Creates the insulin affordability program through which pharmacists provide eligible individuals with prescription insulin for 12 months at a cost not to exceed $50 for a 30-day supply.
A pharmacist that dispenses prescription insulin through the emergency supply or the insulin affordability program may seek reimbursement for the cost of the insulin from the insulin manufacturer.
(Note: This summary applies to this bill as enacted.)